Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01800539
Other study ID # NA_00023642
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date June 2022

Study information

Verified date July 2022
Source Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Based on the need to characterize and improve early intervention services for minority and under-resourced children with ASD, this study translates a manualized and proven training model to examine its impact on the use of evidence-based practices (EBP) by early intervention providers, and to examine its relationship to child and family outcomes. By highlighting the impact of EBP-focused training on participating providers, children, and families, findings of the proposed study have the potential to effect significant change in the organization and delivery of early intervention services for minority and under-resourced children with ASD.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 2022
Est. primary completion date June 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Months to 42 Months
Eligibility Inclusion Criteria for Providers: - Providers must be employed by an Infants and Toddlers Program; and - Serve at least one eligible child with ASD Inclusion Criteria for Families/Children: - Children must be between 12 months, 0 days and 35 months, 30 days of age at entry into the study; - Children must meet criteria on the Autism Diagnostic Observation Schedule (ADOS) for ASD or autism; and - Caregiver and child must be available for all assessments Exclusion Criteria for Families/Children: - Children will be excluded if they are in foster care or wards of the state - Caregiver must be fluent in speaking and understanding the English language

Study Design


Intervention

Behavioral:
Provider Education Model (PEM)
Providers will be trained to use evidence-based practices for early intervention service delivery in the Autism Spectrum Disorder population.

Locations

Country Name City State
United States Kennedy Krieger Institute Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Health Resources and Services Administration (HRSA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Provider Delivery Service Practices Provider measure Baseline and 6 months into treatment
Secondary Change in Baseline Mullen Scales of Early Learning Child measure Baseline and 6 months into treatment
Secondary Change in Baseline Autism Diagnostic Observation Schedule Child measure Baseline and 6 months into treatment
Secondary Change in Caregiver Interaction with Child Caregiver measure Baseline and 6 months into treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism